| Bioactivity | Myr-Tat-PKCβII is a cell permeable protein kinase C β II peptide inhibitor. Myr-Tat-PKCβII mitigates the generation of reactive oxygen species in rat ex-vivo and porcine in-vivo ischemia-reperfusion injury[1]. |
| Sequence | {Myr}-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Cys-Cys-Ser-Leu-Asn-Pro-Glu-Trp-Asn-Glu-Thr |
| Shortening | {Myr}-YGRKKRRQRRRCCSLNPEWNET |
| Formula | C131H220N46O34S2 |
| Molar Mass | 3047.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Generation of Reactive Oxygen Species in Rat ex-vivo and Porcine in-vivo Ischemia-Reperfusion Injury[J]. Circulation, 2023, 148(Suppl_1): A18459-A18459. |